Skip to content

    Subex

    SUBEXLTD
    Information Technology·11 Feb 2026
    Management Summary

    Subex reported a steady Q3 FY26, achieving 2.7% sequential top-line growth and robust normalized EBITDA and PAT margins of 13.1% and 10.8% respectively. The company highlighted the rapid commercialization of its AI-led FraudZap product and a strong order book, indicating positive momentum. While acknowledging the need for accelerated top-line growth, management outlined strategic initiatives focusing on AI integration, Managed Services expansion, and market access through tuck-in acquisitions, committing to discuss providing more formal guidance in the future.

    Highlights

    5

    • Revenue grew 2.7% sequentially to INR 70.79 crores in Q3 FY26.

    • Normalized EBITDA margin improved to 13.1% and Normalized PAT margin to 10.8%.

    • Successfully commercialized FraudZap, an AI-led product, within a year, demonstrating increased agility.

    • Order book remains strong with new logo additions and renewals, and the pipeline is healthy.

    • Onboarded two independent directors, strengthening governance.

    Concerns

    3

    • A one-time exceptional item of INR 4.5 crores was incurred due to new labour code impact for past service liabilities.

    • Top-line growth still 'eludes' the company, though plans are in place for turnaround.

    • No meaningful outcome yet on lost revenue recovery from the Sectrio business, with legal recourse ongoing.

    What Changed1

    vs Q4 FY26

    Guidance items2 → 0 (-2)

    Key financials

    Single quarter

    07 metrics
    1. 01Revenue₹70.79 Cr+2.7%QoQ
    2. 02Normalized EBITDA₹9.2 Cr+26%QoQ
    3. 03Normalized EBITDA Margin13.1%
    4. 04Normalized PAT₹7.68 Cr+96.9%QoQ
    5. 05Normalized PAT Margin10.8%

    Order Book

    medium confidence

    Execution

    Traditional RAFM/ROC products convert revenue later (3 quarters after deal), while AI-led products like FraudZap convert faster (sometimes same quarter).

    Pipeline

    deal pipeline tcv

    Order bookings and pipeline remain healthy.

    "Management notes a strong order book and healthy pipeline, with AI-led products showing faster revenue conversion. They are tracking net new pipeline and running roadshows."

    Source:
    Prepared remarks

    Capital allocation

    1
    medium confidence
    CategoryHeadline
    Liquidity

    Cash ₹150 crores

    Company has surplus cash which it intends to use for tuck-in acquisitions for technology or market access.

    What to watch in Q4 FY26

    5

    FraudZap Revenue Contribution

    next quarter or two quarters
    CurrentEarly stages, no specific numbers provided
    TargetMore confident estimates on revenue mix and contribution

    Why it matters

    FraudZap is a key new AI-led product, and its revenue ramp-up is crucial for future growth.

    I will be, honestly Abhishek, able to answer this maybe in another quarter much better, you know, another quarter or two quarters, because it just feels a little bit early to comment. I want to see this revenue mix starting to shift, actually, and then I'll be able to and team has to hit my milestones, right.

    Risks & concerns

    3
    RiskSeverity

    Geopolitical Uncertainty and Revenue Realization

    Small, mild exposure to countries like Iran and Venezuela where revenue can get stuck, though exposure is controlled and minor. — Management acknowledged

    low

    Tough Talent Market

    The talent market is difficult, but the company is adapting by hiring talent where it is located rather than concentrating in one location. — Management acknowledged

    medium

    Market Readiness for Data Protection Products (PrivaSapien)

    While data protection policies are emerging globally, explicit demand for products like PrivaSapien from telcos outside India has not yet translated into concrete requirements. — Management acknowledged

    medium

    Q&A highlights

    8

    “That's a you've asked a very interesting question. So, for us, I think again, Mahesh to be honest, it's early days, so I'm unable to kind of really answer that question. But what we were wanting to do is, we definitely wanted that said, I wanted to challenge the team to see if they could develop something very, very quickly, which is white coated pretty much. But more importantly, can we commercialize it, take it to market, have a paying customer? All of that has happened within a year.”

    Analyst pressed for specific revenue estimates for FraudZap by 2030, but management declined to provide numbers, citing early stages, indicating uncertainty or unwillingness to commit to long-term forecasts for a new product.

    asked by Mahesh Kumar

    2 min read6 chapters

    Detailed Narrative

    01

    Q3 FY26 Financial Performance Overview

    Subex reported a sequential top-line growth of 2.7% in Q3 FY26, with revenue reaching INR 70.79 crores, compared to INR 68.9 crores in the previous quarter. The company demonstrated strong operational discipline, achieving a normalized EBITDA margin of 13.1% and a normalized PAT margin of 10.8%. PAT, including an exceptional item📎 of INR 4.5 crores related to new labour code impact for past service liabilities, stood at INR 2.9 crores, showing a slight increase from INR 2.8 crores in the prior quarter.

    02

    Strategic Shift Towards AI and FraudZap Success

    A significant highlight of the quarter was the successful commercialization of FraudZap, an AI-led product, within just one year of its conception, reflecting increased agility. Management is prioritizing AI investments, with several AI use cases already live in production environments, and a European customer funding a proof of concept for GenAI agents. This strategic shift is underscored by the company's rebranding to an 'AI native operating model,' aiming for faster revenue conversion compared to traditional products.

    03

    Order Book Health and Revenue Conversion Dynamics

    Subex reported a strong order book, bolstered by new logo additions and renewals, and a healthy pipeline. Management clarified that traditional RAFM/ROC products typically see revenue conversion around three quarters after a deal is announced, following implementation. In contrast, AI-led implementations like FraudZap offer more immediate, straight-line revenue gains, sometimes within the same quarter, which is a key driver for accelerating the AI line of business.

    04

    Multi-pronged Growth Initiatives

    Beyond new product development, Subex is aggressively expanding its Managed Services (MS) offerings, with many recent deals, including a $6 million contract, incorporating a strong MS component. The company is also pursuing a 'Horizon 1 & 2' strategy: Horizon 1 involves reinstituting MS, building new products, and integrating AI into older ROC stacks, while Horizon 2 focuses on an innovation lab exploring new fraud vectors like account takeover, relevant to telcos and OTTs.

    05

    Investor Engagement and Future Outlook

    Management acknowledged investor concerns regarding top-line growth, stating that while 'growth still eludes us a little bit,' a solid plan is in place for turnaround. Nisha Dutt committed to discussing with the board the possibility of providing more specific guidance in future calls to enhance investor confidence. The company also plans to host an Investor Day within the financial year to further engage with the investment community and provide updates on its strategic direction.

    06

    Capital Allocation Strategy and Investments

    Subex currently holds approximately INR 150 crores in cash, which it plans to deploy for 'tuck-in acquisitions' aimed at gaining new technology or market access, rather than large top-line acquisitions. Existing investments, such as OnGrid and PrivaSapien, are performing well; OnGrid is noted as cash-rich, profitable, and recently issued bonus shares, with its fair market valuation to be conducted in Q4.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.